Skip to main content

Mary
R.
Rooney
,
PhD

Assistant Scientist
Mary Rooney

Departmental Affiliations

Primary

Mary Rooney, PhD, MPH, is working to improve approaches to diabetes risk stratification through the use of clinical and novel biomarkers.

Contact Info

Research Interests

Epidemiology; Diabetes; Biomarkers; Cardiovascular disease; Aging

Experiences & Accomplishments
Education
PhD
University of Minnesota
2019
MPH
University of Minnesota
2015
BS
University of Illinois Urbana Champaign
2013
Honors & Awards

2022 Trudy Bush Fellowship for Cardiovascular Disease Research in Women’s Health, American Heart Association, Council on Epidemiology and Prevention;
2021 W.H. Linda Kao Collaboration Award, Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology;
2013 Bronze Tablet Scholar, University of Illinois, College of Applied Health Sciences (Top 3% of graduating college class);
2010-2013 Edmund J. James Scholar, University of Illinois, College of Applied Health Sciences

Select Publications

Selected publications

  • Rooney MR, Tang O, Echouffo Tcheugui JB, Lutsey PL, Grams ME, Windham BG, Selvin E. American Diabetes Association Framework for Glycemic Control in Older Adults: Implications for Risk of Hospitalization and Mortality. Diab Care. 2021;44:1524-1531.

  • Rooney MR, Rawlings AM, Pankow JS, Echouffo Tcheugui JB, Coresh J, Sharrett AR, Selvin E. Risk of Progression to Diabetes Among Older Adults With Prediabetes. JAMA Intern Med. 2021;181(4):511-519.

  • Rooney MR, Alonso A, Folsom AR, Michos ED, Rebholz CM, Misialek JR, Chen LY, Dudley S, Lutsey PL. Serum magnesium and the incidence of coronary artery disease over a median 27 years follow-up in the Atherosclerosis Risk in Communities (ARIC) study and a meta-analysis. Am J Clin Nutr. 2020;111(1):52-60.

  • Rooney MR, Soliman EZ, Lutsey PL, Norby FL, Loehr LR, Mosley TH, Zhang M, Gottesman RF, Coresh J, Folsom AR, Alonso A, Chen LY. Prevalence and characteristics of subclinical atrial fibrillation in a community-dwelling elderly population: the Atherosclerosis Risk in Communities (ARIC) study. Circ: Arrhythm & Electrophysiol. 2019;12(10):e007390.

  • Rooney MR, Harnack L, Michos ED, Ogilvie RP, Sempos CT, Lutsey PL. Trends in use of high dose vitamin D supplements exceeding 1,000 or 4,000 international units daily, 1999-2014. JAMA. 2017;317(23):2448–2450.